LN:PRTC PureTech Health plc

PureTech Health Plc is a cross-disciplinary bio-pharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Internal, and Affiliates. The Internal segment is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. The Affiliates segment is comprised of the programmes within PureTech's Affiliates division. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.This company has ADRs that trade in the U.S. as the symbol PRTC.

287.50 GBP
As of 12/07/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Communication Services
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  01/01/1900
Stock exchange:    London Stock Exchange
Exchange country:   United Kingdom
Market cap:   871,993,352 GBP
Current dividend yield:   0.00%
CUSIP:    
ISIN:        GB00BY2Z0H74
Sedol:      

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy